Trial Profile
Phase IIa trial of paclitaxel gel (OncoGel) in patietns with oesophageal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2007
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- Sponsors Protherics
- 25 Nov 2007 New trial record.